A Pilot Trial of Lirilumab with or without Azacitidine for patients with Myelodysplastic Syndrome

We report the results of a prospective trial of lirilumab in patients with myelodysplastic syndrome(MDS). A total of 10 patients included. Higher-risk patients received lirilumab plus azacitidine, lower-risk received single agent lirilumab. Two patients achieved CR and 5 achieved marrow CR. Although...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Lymphoma Myeloma Leuk
Autors principals: Yalniz, Fevzi Firat, Daver, Naval, Rezvani, Katayoun, Kornblau, Steven, Ohanian, Maro, Borthakur, Gautam, DiNardo, Courtney D., Konopleva, Marina, Burger, Jan, Gasior, Yvonne, Pierce, Sherry, Kantarjian, Hagop, Garcia-Manero, Guillermo
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6750214/
https://ncbi.nlm.nih.gov/pubmed/30001986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2018.06.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars